Search results
Results from the WOW.Com Content Network
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. [ 4 ] [ 5 ] The company's product portfolio includes prescription medicines and vaccines .
This is a list of products manufactured by the multinational pharmaceutical, biologics, and vaccines manufacturing company GSK. Pharmaceutical products 1] ...
The Beecham Group plc was a British pharmaceutical company.It was once a constituent of the FTSE 100 Index.Founded by Thomas Beecham who opened the first factory in St Helens, Lancashire in 1859, Beecham focused on marketing the business by advertising in newspapers and using a network of wholesale agents in northern England and in London, rapidly building up the business. [1]
GlaxoSmithKline (2000–2022) GSK plc (2022–Present) Smith, Kline & French (SKF) was an American pharmaceutical company that is now a part of the British group GSK plc.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
NPS Pharmaceuticals is a biopharmaceutical company focused on bringing orphan products to patients with rare disorders and few, if any, therapeutic options. NPS is advancing two late-stage ...
Under her leadership the consumer products division, one of the world's largest consumer health groups with brands including Panadol, Voltaren and Horlicks, made up nearly a quarter of GlaxoSmithKline's revenues. [12] She took over as CEO of the company in April 2017, [12] [13] making her the first woman to run a major pharmaceutical company. [14]